Aurobindo gets USFDA nod for multi disease treatment injection
Advertisement
New Delhi: Drug firm Aurobindo Pharma today said it has received final approval of the US health regulator to manufacture and market its Dexamethasone Sodium Phosphate injection, used to treat various conditions such as severe allergic reactions, arthritis and blood diseases.
"The company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Dexamethasone Sodium Phosphate injection USP, 4 mg/mL (1 mL, 5 mL and 30 mL vials)," Aurobindo Pharma said in a statement.
The company expects to launch the product by fourth quarter of the current fiscal, it added.
"The approved product has an estimated market size of USD 31 million for the twelve months ending September 2015, according to IMS," Aurobindo Pharma said.
The company's injection is generic, equivalent to Luitpold Pharmaceuticals Inc's Dexamethasone Sodium Phosphate injection in the strength of 4 mg/mL, it added.
"The company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Dexamethasone Sodium Phosphate injection USP, 4 mg/mL (1 mL, 5 mL and 30 mL vials)," Aurobindo Pharma said in a statement.
The company expects to launch the product by fourth quarter of the current fiscal, it added.
"The approved product has an estimated market size of USD 31 million for the twelve months ending September 2015, according to IMS," Aurobindo Pharma said.
The company's injection is generic, equivalent to Luitpold Pharmaceuticals Inc's Dexamethasone Sodium Phosphate injection in the strength of 4 mg/mL, it added.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.